LAPADULA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.200
AS - Asia 849
EU - Europa 653
SA - Sud America 127
Continente sconosciuto - Info sul continente non disponibili 30
AF - Africa 17
OC - Oceania 4
Totale 3.880
Nazione #
US - Stati Uniti d'America 2.157
CN - Cina 356
SG - Singapore 263
DE - Germania 147
UA - Ucraina 141
BR - Brasile 106
GB - Regno Unito 84
HK - Hong Kong 83
FI - Finlandia 76
FR - Francia 48
IT - Italia 47
VN - Vietnam 46
RU - Federazione Russa 29
CA - Canada 26
IE - Irlanda 25
TR - Turchia 23
IN - India 21
IR - Iran 10
PL - Polonia 10
MX - Messico 9
AR - Argentina 8
BD - Bangladesh 8
SE - Svezia 8
JP - Giappone 6
ZA - Sudafrica 6
MA - Marocco 5
NL - Olanda 5
AT - Austria 4
BE - Belgio 4
CH - Svizzera 4
ES - Italia 4
LT - Lituania 4
UZ - Uzbekistan 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
CO - Colombia 3
EC - Ecuador 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EU - Europa 2
HN - Honduras 2
IQ - Iraq 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.852
Città #
Ashburn 221
Woodbridge 218
Fairfield 204
Singapore 139
Ann Arbor 131
San Jose 129
Houston 117
Jacksonville 117
Chandler 102
Hong Kong 83
Cambridge 77
Beijing 76
Seattle 74
Wilmington 71
The Dalles 52
Helsinki 51
Los Angeles 49
Nanjing 49
New York 45
Princeton 42
Lancaster 37
Council Bluffs 31
Munich 31
Dublin 25
Lauterbourg 22
Istanbul 21
Shanghai 18
Columbus 17
Nanchang 17
Jinan 16
Shenyang 16
Dallas 15
Ho Chi Minh City 15
Santa Clara 15
Des Moines 14
Tianjin 14
Changsha 13
San Diego 12
Moscow 11
San Francisco 11
São Paulo 11
Ardabil 10
Milan 10
Phoenix 10
Toronto 10
Hebei 9
Montreal 9
Orem 9
Warsaw 9
Buffalo 8
Frankfurt am Main 8
Hanoi 8
London 8
Redondo Beach 8
Washington 7
Chicago 6
Dearborn 6
Kunming 6
Stockholm 6
Turku 6
Augusta 5
Hangzhou 5
Ningbo 5
Tokyo 5
Atlanta 4
Brescia 4
Brussels 4
Curitiba 4
Lanzhou 4
Lausanne 4
Monmouth Junction 4
Poplar 4
Porto Alegre 4
Rio de Janeiro 4
Tashkent 4
Baku 3
Biên Hòa 3
Bratislava 3
Brooklyn 3
City of London 3
Da Nang 3
Denver 3
Fuzhou 3
Guangzhou 3
Haikou 3
Johannesburg 3
Kansas City 3
Melegnano 3
Mexico City 3
Nuremberg 3
Paris 3
Querétaro 3
Taiyuan 3
Amsterdam 2
Belo Horizonte 2
Bishkek 2
Bogotá 2
Boston 2
Brasília 2
Campinas 2
Totale 2.714
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 235
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 230
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 184
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 183
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 181
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report. 177
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 175
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 171
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 169
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 168
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. 166
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 166
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study 161
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 158
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 148
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 136
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 135
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 135
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals 132
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy. 123
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 120
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 119
Predictors of AIDS-defining events among advanced naïve patients after HAART. 109
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. 107
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 56
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 36
Totale 3.880
Categoria #
all - tutte 16.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022166 0 0 5 10 0 12 7 16 5 30 22 59
2022/2023247 23 5 6 14 25 61 0 29 56 1 10 17
2023/2024245 11 7 25 32 12 48 13 6 55 13 4 19
2024/2025487 8 6 1 68 54 38 32 27 51 48 97 57
2025/2026982 93 93 43 117 158 78 158 45 59 91 40 7
2026/2027108 32 35 41 0 0 0 0 0 0 0 0 0
Totale 3.880